JP2004503246A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004503246A5 JP2004503246A5 JP2002510700A JP2002510700A JP2004503246A5 JP 2004503246 A5 JP2004503246 A5 JP 2004503246A5 JP 2002510700 A JP2002510700 A JP 2002510700A JP 2002510700 A JP2002510700 A JP 2002510700A JP 2004503246 A5 JP2004503246 A5 JP 2004503246A5
- Authority
- JP
- Japan
- Prior art keywords
- antisense compound
- antisense
- ebpα
- disease
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/593,589 US6306655B1 (en) | 2000-06-13 | 2000-06-13 | Antisense inhibition of C/EBP alpha expression |
| PCT/US2001/018803 WO2001096586A1 (en) | 2000-06-13 | 2001-06-11 | Antisense modulation of c/ebp alpha expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004503246A JP2004503246A (ja) | 2004-02-05 |
| JP2004503246A5 true JP2004503246A5 (cg-RX-API-DMAC7.html) | 2005-02-03 |
Family
ID=24375326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002510700A Withdrawn JP2004503246A (ja) | 2000-06-13 | 2001-06-11 | Ｃ／ＥＢＰα発現のアンチセンスモジュレーション |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6306655B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1290204A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004503246A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2001268322A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001096586A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7407943B2 (en) * | 2001-08-01 | 2008-08-05 | Isis Pharmaceuticals, Inc. | Antisense modulation of apolipoprotein B expression |
| EP2336319A1 (en) * | 2002-11-13 | 2011-06-22 | Genzyme Corporation | Antisense modulation of apolipoprotein B expression |
| CA2682082A1 (en) | 2007-03-24 | 2008-10-02 | Genzyme Corporation | Administering antisense oligonucleotides complementary to human apolipoprotein b |
| WO2012142480A1 (en) * | 2011-04-14 | 2012-10-18 | Beth Israel Deaconess Medical Center, Inc. | Chimeric rna oligonucleotides and uses thereof |
| EP2723862B1 (en) | 2011-06-21 | 2018-09-19 | MiNA Therapeutics Limited | Albumin production and cell proliferation |
| EP3985118A1 (en) | 2013-11-22 | 2022-04-20 | MiNA Therapeutics Limited | C/ebp alpha short activating rna compositions and methods of use |
| JP7525578B2 (ja) * | 2013-11-22 | 2024-07-30 | ミナ セラピューティクス リミテッド | Ｃ／ＥＢＰα小分子活性化ＲＮＡ組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU690905B2 (en) | 1993-03-04 | 1998-05-07 | Baylor College Of Medicine | The human C/EBP gene and vectors for its expression |
| US5801154A (en) * | 1993-10-18 | 1998-09-01 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of multidrug resistance-associated protein |
-
2000
- 2000-06-13 US US09/593,589 patent/US6306655B1/en not_active Expired - Lifetime
-
2001
- 2001-06-11 WO PCT/US2001/018803 patent/WO2001096586A1/en not_active Ceased
- 2001-06-11 JP JP2002510700A patent/JP2004503246A/ja not_active Withdrawn
- 2001-06-11 AU AU2001268322A patent/AU2001268322A1/en not_active Abandoned
- 2001-06-11 EP EP01946246A patent/EP1290204A1/en not_active Withdrawn